OpenBiome was founded on a bold belief: that the microbiome holds untapped power to transform human health.

For over a decade, we saw that potential come to life—helping thousands of patients overcome Clostridioides difficile (C. diff) through safe access to investigational fecal microbiota transplantation (FMT) treatments.

When regulatory changes forced us to stop delivering these treatments, it was a heartbreaking shift—not just for us, but for the patients who counted on them. But our mission is far from over.

By becoming the OpenBiome Foundation, we’re stepping into a new chapter with the same unwavering commitment: to accelerate microbiome science and ensure its benefits reach the people who need them most. We will channel our unparalleled biological resources, deep expertise, and sense of urgency to support pioneering research, fight for patient access, and close the gaps that still limit this field’s promise. The science is moving fast—and we’re here to make sure it moves toward impact, equity, and hope.

OpenBiome was founded on a bold belief: that the microbiome holds untapped power to transform human health.

For over a decade, we saw that potential come to life—helping thousands of patients overcome Clostridioides difficile (C. diff) through safe access to investigational fecal microbiota transplantation (FMT) treatments.

We Are
OpenBiome
Foundation

Advancing
Progressive
Ideas.

OpenBiome was founded on a bold belief: that the microbiome holds untapped power to transform human health.

For over a decade, we saw that potential come to life—helping thousands of patients overcome Clostridioides difficile (C. diff) through safe access to investigational fecal microbiota transplantation (FMT) treatments.

We Are OpenBiome Foundation

Advancing Progressive Ideas.

We Are
OpenBiome
Foundation

Advancing
Progressive
Ideas.